Cure and Relapse with Antifungal Therapy by Dr F C Odds (Department ofMicrobiology, University ofLeicester)
The present concern with clinical and laboratory aspects of vaginal candidosis has arisen because of the enormous increase in incidence of vaginal infections due to yeasts of the genera candida and torulopsis that has been noticed over the last decade. Publications of trials of a large range of antifungal preparations in yeast vaginitis abound. The majority of investigators have studied specific antifungal compounds such as polyene antibiotics and imidazole derivatives, although trials of nonspecific preparations such as The choice of therapy offered to physicians confronted with cases of vaginal candidosis is therefore confusingly large. In addition to the basic selections of compounds available for topical therapy, a practitioner must consider the relative efficacies of creams and pessaries, of foaming and nonfoaming pessaries and of 'blunderbuss' preparations containing antibacterial or antitrichomonal in addition to antifungal agents. Individual published comparisons of these preparations tend to further the confusion because they rarely report marked differences in the efficacy of the drugs they compare and they submerge the reader in a welter of figures concerning relief and relapse of different symptoms.
Realistically, an antifungal preparation should be expected only to eliminate yeast pathogens from the female genital tract. Its success in relieving symptoms is dependent on those symptoms being caused exclusively by lesions due to yeast pathogens.
For many years it has been common practice to apply vaginal antifungal agents topically for a period of about two weeks. However, Masterton et al. (1976) recently claimed that less than half of their patients in a sexually-transmitted diseases clinic remained faithful to their treatment regime for such a period. Masterton's group suggested that a three-day intensive course of antifungal treatment is as effective a cure for candidal vaginitis as the traditional fourteen-day course. A search of the literature reveals two studies in which patients were monitored frequently during a two-week course of therapy (Alvarez-Bravo et al. ). In both studies, clearly higher mycological cure rates were attained after Dr F C Odds seven days of treatment than after four. Nevertheless, Masterton's suggestions warrant further investigation.
The present study was designed to investigate the effects of treatment variables such as the type of drug, its formulation and the duration of its application on the successful eradication of yeasts from the vagina. Data from the published world literature on therapy of candidal vaginitis was collated so that the largest possible body of results could be subjected to statistical analysis.
For inclusion in the study, each trial had to satisfy the following criteria:
(1) The diagnosis of vaginal candidosis must have been confirmed by yeast-positive culture of a vaginal swab and/or microscopic observation of yeasts in vaginal samples. The correlation between isolation of yeasts from the vagina and vaginitis has been elegantly demonstrated by Carroll et al. (1973) .
(2) The dosage and duration of treatment must have been clearly stated. In trials where onecourse treatment failures were given additional courses of treatment, such patients were deemed to have been treated for the total time of application of the multiple courses.
(3) The treatment must have been applied only to the vagina. Trials in which, for example, oral antifungals were given concomitantly with topical vaginal preparations were excluded. The preparation tested must have included no concomitant steroids or antibacterial antibiotics. (4) Follow up of therapy must have been carried out within eight days of the end of treatment and/or not less than three weeks after the end of treatment.
(5) Cures were defined solely on the basis of negative mycological findings. Data concerning relief of symptoms such as burning, itching and discharge were considered too subjective for sensible analysis.
Of the 62 publications that fulfilled these conditions, 12 (19%) stated the proportion of their subjects who were diabetics, and 45 (73 %) stated the proportion of their subjects who were pregnant. Only one or two authors reported other factors in their subjects that may have predisposed to candidal infection. The publications reported trials of the following antifungal compounds (number of references in parentheses): the imidazole derivatives clotrimazole (16), econazole (2) and miconazole (8); the polyenes amphotericin B (2), candicidin (10), hamycin (1), methylpatricin (2), nystatin (21), pimaricin (5) , and trichomycin (3); and chlordantoin (5) . Many publications involved studies of more than one compound so the number of data sets for all compounds exceeds the number of publications. Grouped data were compared by x2 tests. Results were considered significant only when the probability that they occurred by chance was P<0.0001.
Mycological Cure Rates ofAntifungal Compounds in Vaginal Candidosis
The relative success of different antifungal agents in the immediate eradication of yeast pathogens from the vagina was compared for those preparations for which a total of at least 99 patients were studied in not less than three separate trials. Only trials in which patients were treated for from six to fifteen days were included, and only mycological cure rates determined within eight days of the end of therapy were considered. The patient group in pimaricin trials consisted largely of pregnant women; for the other preparations the proportion of pregnant patients in each group was similar. Cases from the trials were added together and an overall mycological cure rate was determined.
It may be objected that this procedure introduces a bias in trials with large groups of patients. To confirm the validity of the procedure, the individual mycological cure rates for each preparation in each trial were determined and the mean cure rate, with all trials equally weighted, was calculated. The results (Table 1) were strikingly similar to the overall cure rates determined by case summation, and in no case was there a difference between the results of the two methods significant even at the P= 0.05 level.
From Table I it can be seen that there were striking differences in efficacy of the seven antifungal agents listed. The cure rates for all compounds except pimaricin were significantly higher than that for chlordantoin. Clotrimazole gave a significantly better cure rate than all other drugs except miconazole and candicidin, and miconazole was significantly better than nystatin, pimaricin and chlordantoin. The cure rate for candicidin was significantly better than that of all other polyenes except trichomycin.
Imidazole derivatives as a group (with data for econazole included), whose overall cure rate was 90 % (4078 patients) were significantly better than polyenes as a group (including data for amphotericin B, hamycin and methylpatricin) whose overall cure rate was 79% (2475 patients). This analysis suggests that imidazole-type preparations should be the first choice of treatment of candidal vaginitis and that chlordantoin is unsuitable in this disease.
Antifungal Formulations and their Effect on Mycological Cure Rates
The vehicle in which the antifungal drug was applied appeared to have no effect on the outcome of therapy. Fluid formulations (creams and ointments), with an overall cure rate of 88 % (16 trials, 1963 patients) were not significantly better than solid formulations (tablets and pessaries) which gave an overall cure rate of 85 % (44 trials, 4358 patients). The analysis was performed ac- cording to the same criteria as previously, chlor-It is probable that the low yeast eradication rate dantoin trials being excluded. There was no after less than six days of therapy occurred significant difference between fluid and solid simply because such a short treatment period was formulations for imidazole derivatives and for insufficient for successful mycological cure. Less polyenes analysed separately. easy to explain are the low cure rates found after longer periods of therapy. The overwhelming Duration ofTreatment and its Effect on majority of subjects treated for eighteen days or Mycological Cure and Relapse Rates longer received two or more courses of therapy The data from the trials were used to determine because they remained yeast positive after one the effectiveness of different treatment times in the course. They therefore represent so-called 'intherapy of vaginal candidosis. For inclusion in tractable' cases of candidal vaginitis who should this analysis each treatment time period had to receive more comprehensive antifungal therapy in include data from at least two sources. The re-order to eliminate yeasts from endogenous sults ( Table 2 ) for drugs of all types showed that reservoirs other than the vagina, and who are cure rates after six to seventeen days of treatment known to respond poorly to topical therapy alone. were significantly higher than cure rates after shorter or longer periods of treatment. Similar results were obtained when imidazole derivatives were assessed alone ( Table 3 ) and when polyenes were assessed alone (Table 4) , although the fall off in cure rate at longer treatment times was far less marked for polyenes than for imidazole derivatives. Immediate eradication ofyeasts from the vagina is not the sole criterion of efficacy for an antifungal agent. The effects of treatment should be as permament as possible and the vagina should remain yeast-free (barring reinfection) for at least a period of weeks after therapy before the disease may be claimed to be cured. Unfortunately the data available for the determination of mycological relapses (assessed at least three weeks after the end of treatment) were fewer and more obscure than data for immediate mycological cures. They are presented in Table 5 .
Relapse rates were highest in patients who were treated for the least time, and lowest in the longest treated patients. The relapse rate in patients treated for less than eleven days was not significantly higher than the relapse rate after 11-23 days of treatment, although the probability that the difference arose by chance was P<0.02. Relapse rates in patients treated for six to fifteen days were statistically similar for imidazole derivatives and for polyene antifungal agents (relapse rates respectively 5.3% of 971 patients and 3.8 % of 408 patients).
The conclusions that may be drawn from this study are clear and simple. Effective treatment with minimal relapse in vaginal candidosis, as monitored by mycological findings, requires optimally a treatment regime of about two weeks. The chosen vehicle of the antifungal agent is unimportant but different types of antifungal drugs have different abilities to eliminate yeast pathogens from the vagina.
It may be found that symptomatic relief from the disease can be achieved with very short courses of topical therapy, but it is unlikely that such short courses will produce lasting cures except in the most mildly affected cases. If patients are frequently found to default from twoweek courses of therapy, perhaps the best remedy would be for the physician to take greater pains in increasing his patients' awareness of the need for strict adherance to their treatment regime. He also wondered if a vaginal swab was taken from a woman who had been treated with miconzaole or nystatin whether the antifungal agents would also be transferred and would inhibit fungal growth in culture. Dr Odds said that the majority of authors had used cultural findings.
As to contamination of plates by antifungal agents, both the imidazole derivatives and the polyenes are extremely insoluble in water and if the yeast is spread properly on the plate the antifungal agent would not be expected to diffuse and hence inhibit growth to any significant extent. He appreciated Dr Davies's subsequent point that although nystatin is not supposed to diffuse, a nystatin disc on a plate can give a centimetre zone of inhibition. The majority of authors seemed to have bypassed this problem by plating the swab directly and assuming that although zones of inhibition might be produced, any residual antifungal agent was unlikely to inhibit all the growth on the plate. Dr R S Morton (Sheffield) said that rather than indiscriminate use of the term 'relapse' he would like to have seen the study concerned with 'recurrence' and these recurrences subsequently subdivided into 'relapse' and 'reinfection', whether autoinfection or infection by the consort. Dr Odds agreed. Recurrence was indeed a far better term for what had been measured, the reappearance of yeasts in the vagina.
General Discussion
Professor Hurley (Chairman) asked whether the terms 'relapse', 'recurrence' and 'reinfection' could be more closely defined. They did not seem to have the same meaning to all microbiologists as they did to clinicians. Dr R S Morton said that the terms could be distinguished but sometimes the clinical conditions could not. One might not be able to decide whether a recurrence meant that the consort had reinfected the patient or that the treatment had failed.
One simple distinction was based on timing. If the patient underwent two follow-up tests in the week after completing treatment, then any recurrence was a reinfection. Various definitions were possible and in evaluating studies it was important to consider the question. Dr D W R Mackenzie (London) said that laboratories did not generally distinguish between one strain of Candida albicans and another. If they did so, and if it were found that a second infection resulted from the same strain as the original one, this might be considered evidence of relapse. Conversely, if a second strain were demonstrated in the latter case, this would seem to represent reinfection. Laboratories now had the capacities to carry out these studies and they might be very helpful in making this distinction. Professor J R Hobbs said that modern methods of washing bedclothes in lukewarm water with enzymes may not kill candida in the way that more oldfashioned boiling methods did. This in itself might be one reason why the fungus was prevalent. Professor Hurley said that she suggested that patients boil their underwear or wear disposable underwear.
Dr G D Rees (Swansea) asked if any experiments to assess the viability of candida when isolated from the human body had been carried out. Dr Y M Clayton said that candida did not remain viable in skin keratin after the skin scales had been shed, as long as did ringworm fungi. Indeed, the organism died relatively quickly. Dr R R Davies (London) said that candida had been isolated from the soil. But since it was carried in the alimentary tracts of animals, it was impossible to know how recently the soil had been contaminated. Professor J R Hobbs said that they had been interested in the problem of how soon children become sensitized to candida. Of 36 children who were studied by Dr S Malka, all had become positive to candida within six weeks and it therefore seemed a ubiquitous organism, although the fact that the mothers of these children had recently been pregnant must not be overlooked.
Dr D W R Mackenzie (London) said that outside the body, candida is very susceptible to reduced humidity. He had kept 50 strains from clinical isolates in discs of sterile filter paper at room humidity and within six months none was viable. Dr F C Odds added, that, conversely, he had kept the yeasts in distilled water in test tubes on the bench and in those conditions they would survive for many years. Mr J M Emens (Birmingham) said that outpatients with vaginal thrush were often given a vaginal cream or pessary but were not advised to treat the vulva and perianal area concurrently. He wondered if this was important. Dr J D Oriel said that this question related to the source of any possible reinfection. In theory, reinfection was possible from the gut, from the male partner, or possibly from the bedclothes. There was no evidence suggesting which of these was the most important. It therefore seemed necessary to exploit all the possibilities. Though some clinicians disagreed he felt it necessary to treat the gut reservoir. In addition, attention should be devoted to the male partner and a different type of detergent may be necessary for the bedclothes. Miss A Boutwood (London) asked if the incidence of candida in sponges and flannels had been established. It was her impression that their repeated use might cause reinfections. Dr R R Davies (London) said that Staphylococcus aureus could survive on soap containing hexachlorophene. It might be appropriate to try to isolate candida from soap. Professor Hurley said that Candida albicans was known to survive in disinfectant hand creams for eight days or more. Dr R Y Cartwright (Guildford) said that 2 patients with vaginal candidiasis resistant to treatment had been found, on questioning, to use special flannels, especially after intercourse. He had obtained these flannels and had grown candida from them.
He said that the tacit division of patients into those with acute infection and those with chronic reinfection was important in relation to the work of Masterton and his colleagues. In their threeday trials they carefully pointed out that such a course might be effective only in an acute first attack. A short course was quite inappropriate for patients with recurrent attacks or those who had had candidiasis for a long period. Even so, much more work needed to be done to establish these data.
In a previous investigation Masterton had followed patients on a regimen of six days or longer to find out when they actually stopped the treatment. The vast majority stopped treatment when the symptoms abated, usually about three to four days. It was for this reason that they chose a three-day course. He personally believed that the most important factor in treating the chronic patient was the attitude of the doctor in explaining the necessity to undertake the full treatment course. Dr A B Gyening (London) asked whether the trials cited by Dr Odds gave details of how many pessaries were put into the vagina and how long they remained there, and whether these two variables played any role in the rate of cure. Dr F C Odds said that his analysis had not attempted to cover the actual dosage of antifungal agent given to the patient, nor did he know how long the pessary stayed in the vagina. However, manufacturers had worked out very carefully the minimum effective dose for treating patients with their recommended courses, and in all the trials the patients were treated either with the manufacturer's minimum recommended dose or some multiple of it. The patients therefore received at least the amount of the manufacturer's recommendation and with the possible exception of chlordantoin, results suggested that these doses had been accurately assessed. Professor J R Hobbs thought it would be a considerable step forward to attempt to define vaginal candidosis and vaginal candidiasis. He had previously questioned whether it was simply that with the latter the patient complained. He had been reminded of Raymond Greene's dictum relating to the malignancy of thyroid nodules: 'Does the criminal change his character at the moment of arrest?' He told the Chairman that he was indeed considering a distinction between the conditions. Dr R S Morton supported this distinction. He believed that there may be a state of candidosis, a 'happy symbiosis' in which the fungus does the patient no harm until one of the predisposing factors becomes operative. Professor Hurley (Chairman) said that it was undeniable that Candida albicans or any other organism present in the bowel must transiently be carried in the lower part of the vagina. But she did not believe that Candida albicans was part of the resident flora of the vagina. Dr Laylor's work suggested that in middle age everyone had oral thrush. Dr A Palmer (Leeds) thought it most important to establish whether the organism could exist as a commensal or not. In their trial, since they did not believe that they could diagnose it clinically, they felt ethically justified in treating some patients with placebo for one week. Of these, 8 % were culture positive at the beginning, but culture negative at the end of one week. After treatment, with swabs taken one week later, 8-10 % were positive again. And at three months, 10% were again positive. The constancy of this figure of 10% made him respectfully disagree with the Chairman's view about the absence of any commensal condition. Professor Hurley (Chairman) said that her current opinion was the reverse of her earlier one. A ridiculous situation had in the past been reached in clinical microbiology in which the microbiologist believed candidal vaginitis to be a clinical diagnosis and the clinician believed it to be a mycological diagnosis. The two groups rarely seemed to have discussed the problem. The situation had now improved, if only to the point of admitting that a problem existed.
She agreed with Dr Palmer that one could not talk about a mycological cure and a symptomatic cure. It was indeed the patient who counted. And sometimes there were microbiological errors because the clinician had sampled the wrong place. It was much better for the clinician to sample the area where he saw the vaginitis rather than the posterior fornix, the cervix, or the introitus. Professor J R Hobbs suggested that candidosis might be defined as a condition in which only the culture had been positive many times at a certain site, whereas in candidiasis additional factors such as local reaction were superimposed. Dr F C Odds thought that the problem might be resolved, semantically at least, by considering the possibility of subclinical infections with candida. Professor Hurley said that the presence of the fungus might of course prognosticate disease. But in experimental conditions, two factors were involved. One was the size of the inoculum which did not seem to be very important with Candida albicans given intradermally or subcutaneously. The other was the site of infection. Very large incolcula of Candida albicans painted onto the intact skin had no effect. Only if they were covered with an occlusive dressing would thrush infection develop. Older experiments on oral thrush had shown similar results. It was not possible to induce the condition in newborn lambs simply by putting the fungus into their mouths. But if they were weakened or debilitated in any way or there was damage to the mucous membrane then thrush developed. Thus two factors were always involved. Mr A Pentecost (Maidstone) said that Dr DeNollin had shown that fungicidal agents acted directly on the fungal cells. He therefore asked Professor Hobbs why the integrity of the immunological system was important. Professor J R Hobbs said that such integrity might decide whether reinfection, which seemed so common, would become established or not.
Dr R Y Cartwright (Guildford) said that in one instance at least Torulopsis glabrata had been reported to be resistant to miconazole. He asked Dr De Nollin if she had examined any strains of torulopsis by electron microscopy to establish why this resistance to miconazole might occur. Dr S De Nollin said that the strains that she had tried all had the same sensitivity to the drug as did candida. She could therefore not show resistance, which she thought must be due to some specifically in vivo conditions. Dr R Y Cartwright (Guildford) said that in the reported case of therapeutic failure of Torulopsis glabrata vaginitis, the MIC reported for the organism was 1000 ug/ml, which would be generally thought of as resistant. Dr R S Morton asked Professor Hobbs about the role of antibiotics in the immune response. For example, he wondered if women having recurrent thrush should be stopped from taking antibiotics for acne or to suppress chest infections. Professor J R Hobbs said that some drugs used to kill the organism actually inhibited the chances of the phagocytes processing the antigen. They 'could not digest the organism if their own enzymes were inhibited. It was known for example that sulfonamides definitely stopped phagocytes from killing candida. These drugs were very effective in killing streptococcus but if candida were present at the same time the phagocytes would stop processing it.
In patients with good immune status, the memory cells would probably carry them through until the treatment was finished. But long courses or severe viral infections would cause suppression. He had seen cases of perianal candidiasis in patients probably suffering from viral diarrhceas who were over-treated with antibiotics. The fungus became established at a time when the T-cells were depressed. The T-cells could be depressed by influenza for six weeks to a year; for hepatitis they could also be depressed for a year. And this viral depression of T-cells was alarming. In using antibiotics in viral infections the conditions favoured the establishment of candida. In some males, the situation had been reversed by increasing the immunity. At present unfortunately, the evidence was anecdotal rather than epidemiological. Dr R S Morton thought that the evidence might be available. Very many women seen at special clinics had received a diagnosis of cystitis when in fact they had thrush. They had been given antibacterial treatments and so they may provide appropriate subjects for measurements. Dr G D Rees (Swansea) asked if there might be some analogy between what was called reinfection with candida and latent syphilis, where for some unknown reason it suddenly flared up? He was speaking particularly of a candidal flare-up for no apparent reason in the elderly female.
Professor J R Hobbs said that blood levels of thymosin could now be measured and they fell off markedly around the menopause. Indeed a number of old-age autoimmune diseases were now believed to be due to a lack of T-cell regulation. There was no doubt of an increased susceptibility around this time and new treatments were becoming available for revitalizing the T-cells although it remained to be seen in what percentage of cases this could be achieved.
In patients with a first attack of acute vaginal candidiasis, he had found no immunological abnormalities whatever. In 16 chronic patients, however, they had found a clear depression of T-cell responses. He believed that these patients were in a different category from the ordinary acute cases, but how commonly they occurred among candidiasis patients in general he did not know. Dr R S Morton said that of the 200-250 women seen each year for the last five years, some 4-6 of them had recurrent attacks for which no reason could be found. In his experience, therefore, the rate of persistent recurrences was perhaps 3 % of all cases.
Dr A Palmer (Leeds) suggested that another predisposing cause was promiscuity. He found it to be the commonest predisposing cause for recurrent candidal infection among gynecological patients. Dr R S Morton agreed that it was a factor. All sexually transmissible diseases were increasing at present and candidiasis was increasing in parallel. However, he did not think it was a major factor. Dr P Rodin (London) had analysed data on the epidemiology of candida infections derived from the Department of Health and had shown an increase in every third quarter, thus paralleling gonorrhoea and nonspecific urethritis. However, it was known that many of the candidal diagnoses returned to the Department of Health were based on positive cuitures from patients who had sometimes come for other reasons. The Departmental figures gave total diagnoses for the year, not total numbers of patients attending. In an attempt to establish a denominator he related the incidence to total diagnoses and found that the percentage was constant. About 20% of the diagnoses in women were of candida. It was therefore misleading simply to plot the crude figures. Much more information was needed.
He noted from Dr Morton's figures a decrease in 1975 and thought that this might be due to good contact tracing, as with gonorrhoea in Sheffield. However, he wondered whether the percentage had actually increased and then fallen during that year. Dr R S Morton had no data on seasonal incidence. It might be argued that as with gonorrhoea or urethritis it was a feature of the third quarter of the year because more people attended the clinics.
Neither did he know why the figures fell in 1975. They had made no fundamental changes.
They had come to understand more about the bowel and its role in recurrences but they had not established how many cases were first infections and how many were recurrences and their next step was to attempt to make this distinction. Professor Hurley (Chairman) had also wondered whether Dr Morton had shown a genuine rise in incidence or whether more patients with thrush had been going to his clinic. Dr R S Morton said that his total number of new patients was going up and yet the number diagnosed as having candidiasis was going down. He suspected this was because there were fewer recurrent cases.
Taking up the Chairman's point that the incidence of pregnancy thrush in her population was remarkably constant, he said that some 60-70% of women attending special clinics were on the pill and pregnancy was a much less common feature of their work than it was five years ago. He agreed with the Chairman that the incidence of pregnancy itself was declining. Professor J R Hobbs stressed the importance of Dr Rodin's finding in relation to a definition of the disease. If patients with candidiasis were defined as those with positive cultures attending special clinics then the definition was meaningless because most of them attend for some other reason. He thought it necessary to define candidiasis as an acute symptomatic lesion which was the first reason for presentation. This definition then embraced those patients whose candida had brought them to the clinic. Professor Hurley (Chairman) said that she had already published a paper on criteria for diagnosis of candidal vulvovaginitis. If there were signs of clinical vulvovaginitis and the laboratory could isolate Candida albicans in the lesions, that, so far as she was concerned, was candidal vulvovaginitis. If there were thrush plaques and the laboratory could not isolate the fungus (although usually they could) she would still accept that as candidal vulvovaginitis because it was known that if the sampling were repeated two or three times, the fungus would eventually be isolated. In response to Professor Hobbs, she said that concurrent gonorrheea was not very likely to occur. Professor J R Hobbs said that for treatment purposes the most meaningful trials would be on patients from whom concurrent disease had been excluded. Dr J D Oriel agreed. He went on to question the importance of promiscuity. The patients who are seen in venereology departments were sexually active people, and some of them also had candidosis. But it was difficult to relate the two. He would require studies of the incidence of candida, other factors excluded, in relation to the number of sex partners, both life time and per unit time before he would accept the relation. Dr A Palmer (Leeds) said that it was necessary to define the patient groups. But certainly in gynacological practice he was so confident that if patients failed to respond to two courses of treatment he would actively seek the partner. Dr J B D Milne (Bristol) said that some of the more persistent cases of candidal vaginitis seen in Bristol had been in virgins. Dr F C Odds said that there was anecdotal evidence in the United States of America that the incidence of vaginal candidiasis was very high in nunneries. Dr A Palmer (Leeds) said that these facts were unsubstantiated and that the whole subject was surrounded by a lack of hard data. Dr P Rodin (London) said that patients who had been given antibiotics had an increase in the carriage of candida in the mouth, the rectum and the vagina and that this increase occurred in a comparatively short time. It was generally felt that candida was spread from person to person rather than contracted from the environment and he wondered how it increased so rapidly. Perhaps laboratory methods were not detecting it when it was there, but only when antibiotics had suppressed other organisms. Alternatively, it might be picked up from elsewhere. He had seen a recent German report in which candida had been looked for in various articles of food and also in toothbrushes. It has not been found in the food but was found in 15 % of toothbrushes. Such brushes seemed an ideal place for it to persist. Professor Hurley (Chairman) said that in relation to the first possibility, until perhaps ten years ago some laboratories were not good at specific identification of yeasts. This situation had improved mainly because of the germ tube test which was highly specific and not difficult to perform. Laboratories participated in quality control trials in Britain and elsewhere and would now expect about 95 % agreement on Candida albicans identification. In addition, the sampling errors to which she had already referred must be considered.
Professor J R Hobbs said that Dr Lehrer who had been involved in the candida killing test believed that much of the increased candida following antibiotic therapy was due to the inhibition of the ability of normal phagocytes to kill the fungus. However, such cells did not need to surround the candida to kill it. Activated phagocytes could release short range cytotoxins which would go across the mucosa and kill the fungus in the vagina without being present there themselves. This killing was a feature of both lymphocytes and phagocytes if they were present in sufficient numbers and were sufficiently close and such killer cells are included within the term 'K-cells'. Dr P Rodin (London) considered this to be an important point because in some patients, even with severe candidal infection, only epithelial and candidal cells were seen. No polymorphs were present. Dr R S Morton agreed that few pus cells were found in most cases of vaginal candidiasis. Like other fungal infections, it was a disease on the skin rather than in it. Professor Hurley (Chairman) concurred with this view. Pus cells were not characteristic of candidal vulvovaginitis. If they did occur they were more often related to cervicitis. Professor J R Hobbs said that nonetheless some of the mediators would go across the membrane even if the cells were not present. The production of these mnediators was certainly inhibited by antibiotic therapy, by sulphonamides, for example, and tetracyclines, particularly if cortisol were used at the same time. These conditions were all known to predispose to candidiasis. Dr Lehrer's view was expressed because there was such a good correlation between the antibiotics that appeared particularly to predispose to candidiasis and those which inhibited candida killing. Professor Hurley (Chairman) said that it was not appropriate for her to produce a 'Chairman's summary' since many different views had been expressed.
She did, however, wish to thank all speakers for an interesting, enjoyable and, she hoped, scientifically profitable afternoon. In addition she wished to thank Janssen Pharmaceutical for having arranged this half-day Symposium.
